1 results match your criteria: "Robert Debré Hospital and University Paris 7 Denis Diderot[Affiliation]"
Long-acting lanreotide in adolescent girls with constitutional tall stature.
Horm Res
June 2009
Department of Pediatric Endocrinology and Diabetology, INSERM U690 and Centre de Référence des Maladies Endocriniennes Rares de la Croissance, Robert Debré Hospital and University Paris 7 Denis Diderot, Paris, France.
Background/aims: The aim of the study was to evaluate the efficacy and safety of lanreotide prolonged release (PR) 30 mg (long-acting lanreotide) in girls with constitutional tall stature (CTS).
Methods: This open label prospective study included 35 girls (mean age 12.6 years) with CTS and a predicted adult height of >180 cm.